Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: Potential to improve diagnosis and prognosis

Cellular Oncology

Volumn 30, Issue 1, 2008, Pages 13-26

  Barboro, Paola ^a   Rubagotti, Alessandra ^a,b   Orecchia, Paola ^c   Spina, Bruno ^a   Truini, Mauro ^a   Repaci, Erica ^a   Carmignani, Giorgio ^b   Romagnoli, Andrea ^b   Introini, Carlo ^a   Boccardo, Francesco ^a,b   Carnemolla, Barbara ^a   Balbi, Cecilia ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

Biological markers; Bladder carcinoma; Diagnosis; Nuclear matrix proteins; Prognosis; Proteomics

Indexed keywords

ACTIN; ACTININ; ACTININ ALPHA 1; CYTOKERATIN 1; CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN 5; CYTOKERATIN 7; CYTOKERATIN 8; DESMIN; FIBRINOGEN; FIBRINOGEN BETA CHAIN PREPROPROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HETEROCHROMATIN PROTEIN 1; LAMIN A; LAMIN B; LAMIN C; NUCLEAR MATRIX PROTEIN; NUCLEAR MATRIX PROTEIN 265; PROTEIN P54; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SERUM ALBUMIN; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS MATRIX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MUSCLE CANCER; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR MATRIX-ASSOCIATED PROTEINS; PROGNOSIS; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 38549086796     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. I. Alberti, S. Parodi, P. Barboro, P. Sanna, G. Nicolò, C. Allera, E. Patrone, S. Galli and C. Balbi, Differential nuclear matrix-intermediate filament expression in human prostate cancer in respect to benign prostatic hyperplasia, Cancer Lett. 109 (1996), 193-198.
2. I. Alberti, P. Barboro, M. Barbesino, P. Sanna, L. Pisciotta, S. Parodi, G. Nicolò, F. Boccardo, S. Galli, E. Patrone and C. Balbi, Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer, J. Cell. Biochem. 79 (2000), 471-485.
3. P. Barboro, C. D'Arrigo, A. Diaspro, M. Mormino, I. Alberti, S. Parodi, E. Patrone and C. Balbi, Unraveling the organization of the internal nuclear matrix: RNA-dependent anchoring of NuMA to a lamin scaffold, Exp. Cell Res. 279 (2002), 202-218.
4. P. Barboro, A. Rubagotti, F. Boccardo, B. Carnemolla, C. D'Arrigo, E. Patrone and C. Balbi, Nuclear matrix protein expression in prostate cancer: possible prognostic and diagnostic applications, Anticancer Res. 25 (2005), 3999-4004.
5. F. Boccardo, A. Rubagotti, G. Carmignani, A. Romagnoli, G. Nicolò, P. Barboro, S. Parodi, E. Patrone and C. Balbi, Nuclear matrix proteins changes in cancerous prostate tissues and their prognostic value in clinically localized prostate cancer, Prostate 55 (2003), 259-264.
6. C. Bottino, R. Castriconi, D. Pende, P. Rivera, M. Nanni, B. Carnemolla, C. Cantoni, J. Grassi, S. Marcenaro, N. Reymond, M. Vitale, L. Moretta, M. Lopez and A. Moretta, Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule, J. Exp. Med. 198 (2003), 557-567.
7. G. Brunagel, R.E. Schoen, A.J. Bauer, B.N. Vietmeier and R.H. Getzenberg, Nuclear matrix protein alterations associated with colon cancer metastasis to the liver, Clin. Cancer Res. 8 (2002), 3039-3045.
8. G. Candiano, M. Bruschi, L. Musante, L. Santucci, G.M. Ghiggeri, B. Carnemolla, P. Orecchia, L. Zardi and P.G. Righetti, Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis, Electrophoresis 25 (2004), 1327-1333.
9. J.E. Celis, P. Celis, H. Palsdottir, M. Ostergaard, P. Gromov, H. Primdahl, T.F. Orntoft, H. Wolf, A. Celis and I. Gromova, Proteomic strategies to reveal tumor heterogeneity among urothelial papillomas, Mol. Cell. Proteomics 1 (2002), 269-279.
10. J.E. Celis, I. Gromova, J.M. Moreira, T. Cabezon and P. Gromov, Impact of proteomics on bladder cancer research, Pharmacogenomics 5 (2004), 381-394.
11. P.G. Chu and L.M. Weiss, Keratin expression in human tissues and neoplasms, Histopathology 40 (2002), 403-439.
12. D.S. Coffey, Nuclear matrix proteins as proteomic markers of preneoplastic and cancer lesions, Clin. Cancer Res. 8 (2002), 3031-3033.
13. R. Coradeghini, P. Barboro, A. Rubagotti, F. Boccardo, S. Parodi, G. Carmignani, C. D'Arrigo, E. Patrone and C. Balbi, Differential expression of nuclear lamins in normal and cancerous prostate tissues, Oncol. Rep. 15 (2006), 609-613.
14. F. De Lucia, J.Q. Ni, C. Vaillant and F.L. Sun, HP1 modulates the transcription of cell-cycle regulators in Drosophila melanogaster, Nucleic Acids Res. 33 (2005), 2852-2858.
15. E.P. Diamandis, How are we going to discover new cancer biomarkers? A proteomic approach for bladder cancer, Clin. Chem. 50 (2004), 793-795.
16. J.L. Fleiss, Statistical Methods for Rates and Proportions, 2nd edn, John Wiley & Sons, New York, 1981.
17. K.J. Fuller, R.D. Issels, D.O. Slosman, J.G. Guillet, T. Soussi and B.S. Polla, Cancer and the heat shock response, Eur. J. Cancer 30 (1994), 1884-1891.
18. R.H. Getzenberg, B.R. Konety, T.A. Oeler, M.M. Quigley, A. Hakam, M.J. Becich and R.R. Bahnson, Bladder cancer-associated nuclear matrix proteins, Cancer Res. 56 (1996), 1690-1694.
19. T. Habuchi, M. Marberger, M.J. Droller, G.P. Hemstreet, 3rd, H.B. Grossman, J.A. Schalken, B.J. Schmitz-Dräger, W.M. Murphy, A.V. Bono, P. Goebell, R.H. Getzenberg, S.H. Hautmann, E. Messing, Y. Fradet and V.B. Lokeshwar, Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers, Urology 66 (2005), 64-74.
20. J. Heukeshoven and R. Dernick, Improved silver staining procedure for fast staining in PhastSystem development unit. I. Staining of sodium dodecyl sulfate gels, Electrophoresis 9 (1988), 28-32.
21. K. Holzmann, C. Gerner, A. Poltl, R. Schafer, P. Obrist, C. Ensinger, R. Grimm and G. Sauermann, A human common nuclear matrix protein homologous to eukaryotic translation initiation factor 4A, Biochem. Biophys. Res. Commun. 267 (2000), 339-344.
22. S.K. Hong, C. Kwak, H.G. Jeon, E. Lee and S.E. Lee, Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy?, Urology 65 (2005), 697-702.
23. B. Honore, U. Baandrup and H. Vorum, Heterogeneous nuclear ribonucleoproteins F and H/H' show differential expression in normal and selected cancer tissues, Exp. Cell Res. 294 (2004), 199-209.
24. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal and M.J. Thun, Cancer statistics. 2006, Cancer J. Clin. 56 (2006), 106-130.
25. Hsα expression is associated with the metastatic phenotype in breast cancer, Cancer Res. 60 (2000), 3359-3363.
26. J.P. Klein and M.L. Moeschberger, Survival Analysis: Techniques for Censored and Truncated Data, Springer, New York, 1997.
27. B.R. Konety, T.S. Nguyen, R. Dhir, R.S. Day, M.J. Becich, W.M. Stadler and R.H. Getzenberg, Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4, Clin. Cancer Res. 6 (2000), 2618-2625.
28. T. Lebret, R.W. Watson, V. Molinie, A. O'Neill, C. Gabriel, J.M. Fitzpatrick and H. Botto, Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma, Cancer 98 (2003), 970-977.
29. C. Lengauer, K.W. Kinzler and B. Vogelstein, Genetic instabilities in human cancers, Nature 396 (1998), 643-649.
30. V.B. Lokeshwar, T. Habuchi, H.B. Grossman, W.M. Murphy, S.H. Hautmann, G.P. Hemstreet, 3rd, A.V. Bono, R.H. Getzenberg, P. Goebell, B.J. Schmitz-Dräger, J.A. Schalken, Y. Fradet, M. Marberger, E. Messing and M.J. Droller, Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers, Urology 66 (2005), 35-63.
31. B. Nisman, V. Barak, A. Shapiro, D. Golijanin, T. Peretz and D. Pode, Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma, Cancer 94 (2002), 2914-2922.
32. nrb isoforms in human breast cancer, BMC Cancer 1 (2001), 15.
33. K.J. Pienta, A.W. Partin and D.S. Coffey, Cancer as a disease of DNA organization and dynamic cell structure, Cancer Res. 49 (1989), 2525-2532.
34. I. Pino, R. Pio, G. Toledo, N. Zabalegui, S. Vincent, N. Rey, M.D. Lozano, W. Torre, J. Garcìa-Foncillas and L.M. Montuenga, Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer, Lung Cancer 41 (2003), 131-143.
35. E.Y. Popova, D.F. Claxton, E. Lukasova, P.I. Bird and S.A. Grigoryev, Epigenetic heterocromatin markers distinguish terminally differentiated luekocytes from incompletely differentiated leucemia cells in human blood, Exp. Hematol. 34 (2006), 453-462.
36. J.P. Stein, G. Lieskovsky, R. Cote, S. Groshen, A.C. Feng, S. Boyd, E. Skinner, B. Bochner, D. Thangathurai, M. Mikhail, D. Raghavan and D.G. Skinner, Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients, J. Clin. Oncol. 19 (2001), 666-675.
37. M. Segawa, K. Niino, R. Mineki, N. Kaga, K. Murayama, K. Sugimoto, Y. Watanabe, K. Furukawa and T. Horigome, Proteome analysis of a rat liver nuclear insoluble protein fraction and localization of a novel protein, ISP36, to compartments in the interchromatin space, FEBS J. 272 (2005), 4327-4338.
38. L.H. Sobin and C.H. Wittekind, TNM Classification of Malignant Tumours, 5th edn, John Wiley & Sons, New York, 1997.
39. F.K. Storm, D.M. Mahvi and K.W. Gilchrist, Hsp-27 has no diagnostic or prognostic significance in prostate or bladder cancers, Urology 42 (1993), 379-382.
40. G.V. Tolstonog, G. Li, R.L. Shoeman and P. Traub, Interaction in vitro of type III intermediate filament proteins with higher order structures of single-stranded DNA, particularly with G-quadruplex DNA, DNA Cell Biol. 24 (2005), 85-110.
41. D. Zink, A.H. Fischer and J.A. Nickerson, Nuclear structure in cancer cells, Nat. Rev. Cancer 4 (2004), 677-687.